COPILOT-HF: Cooperative Program for ImpLementation of Optimal Therapy in Heart Failure
Status:
Not yet recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
This is a randomized, open-label, initiative within the Mass General Brigham healthcare
system testing two remote care strategies for optimizing the prescription of
guideline-directed medical therapies in patients with heart failure, regardless of left
ventricular ejection fraction (LVEF).